Peginterferon alpha-2b biosimilar (Zydus Cadila)

聚乙二醇干扰素α-2b生物类似药 (Zydus Cadila)

Report date: 2022/01/24 09:34:26

Base Information

Drug NamePeginterferon alpha-2b biosimilar (Zydus Cadila)
Drug Alias NamePeg IFN α-2b聚乙二醇干扰素α-2b生物仿制药 (Zydus Cadila)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis BHIV Infections +[4
Global Approved IndicationsHepatitis CHepatitis BCondylomata Acuminata
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2014/01/01
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesZydus Cadila
Active IndicationsHepatitis CHepatitis BCondylomata Acuminata
Inactive IndicationsHIV Infections

Other Information

ATC CodeL03AB10
Related LinksN/A